Diagnostics Sector - Secular Up-Cycle in Healthcare & Diagnostics
Indian Healthcare and Diagnostic Services industry is experiencing a multi-year growth phase driven by expanding chronic care requirements, rising...
52 Views
Dr. Lal Pathlabs: Volume-Led Growth, Steady Margin Visibility Stays. Upgrade to BUY
Dr Lal Pathlabs (DLPL) is expected to sustain steady revenue momentum, led by (1) steady patient and sample volume growth, with strategy of no...
184 Views
Pharma and Healthcare: Q1FY26: Steady Revenues, Margins Under Pressure
he India Pharma and Healthcare sector is expected to see steady revenue growth. However, EBITDA margins are expected to show a decline for Q1FY26E
284 Views
Pharmaceuticals: US to cut Rx drug price, no impact on generics
The US president Donald Trump signed an “Executive Order” (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations
216 Views
HSIE Results Daily: SBI Life Insurance, Godrej Properties, SRF, AU Small Finance Bank
SBILIFE’s H1FY25 VNB printed at INR24.2bn (+2.5% YoY), as the VNB margin softened to 26.8% (-180bps YoY) on the back of a higher share of ULIP in...
370 Views